• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Transcelerate Biopharma recognizes CCRC, CPI certification for good clinical practice

Transcelerate Biopharma recognizes CCRC, CPI certification for good clinical practice

January 15, 2014
CenterWatch Staff

The Association of Clinical Research Professionals (ACRP) has learned that TransCelerate Biopharma now recognizes certification through the Certified Clinical Research Coordinator (CCRC) and Certified Physician Investigator (CPI) programs of ACRP's affiliate, the Academy of Clinical Research Professionals, as evidence of Good Clinical Practice (GCP) training.

This development means that TransCelerate's membership of pharmaceutical and biotechnology companies with R&D operations, including 17 firms working together to create efficiencies within the clinical trials process, will save time and resources by not requiring CCRCs and CPIs involved in their trials to complete redundant GCP training for each and every new study team they join. TransCelerate launched in 2012 to advance innovation in R&D, identify and solve common R&D challenges, and further improve patient safety with founding members AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer, Roche and Sanofi.

According to various laws, regulations and/or standard operating procedures across the global clinical research enterprise, every study coordinator, principal investigator (PI) and sub-investigator must complete some basic level of GCP training for each trial on which they work. They also are typically required to "re-do" a more intensive GCP training every two years (sometimes more often). Thus, PIs or coordinators working at sites running multiple trials likely have to complete GCP training for each one.

"As you can imagine, this is a time-consuming chore for coordinators and PIs, it is expensive for sites and sponsors to develop the training or provide time for staff to take the training and it duplicates efforts and documentation over and over again," said Morgean Hirt, ACA, director of certification for ACRP. "Now, TransCelerate member companies are standardizing and recognizing each other's GCP training courses. By furthermore recognizing that the Academy's rigorous certification process for CCRCs and CPIs provides a solid grounding in the tenets of GCP for research involving human volunteers, much training time and effort will be saved when these companies undertake their own studies and when they engage in cooperative research projects with one another."

In other words, any clinical research professional who has a current CPI or CCRC designation will be able to use that as evidence that retaking GCP training is not necessary if they are working on a trial for one of the TransCelerate companies. This highlights the tangible value of certification through the Academy's programs, which have produced more than 28,500 certificants in more than 60 countries since 1992 (including the CPI, CCRC, and Certified Clinical Research Associate [CCRA] programs) and also have been accredited independently through the National Commission for Certifying Agencies.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing